Retatrutide 20mg
€130.00
Mechanism & Benefits
Targets multiple metabolic pathways
Retatrutide is an investigational peptide that activates GLP-1, GIP, and glucagon receptors simultaneously. This triple-agonist mechanism is designed to influence appetite regulation, energy expenditure, and metabolic function.
Supports significant weight reduction
By helping reduce hunger and increase feelings of fullness, retatrutide may support substantial and sustained weight loss when combined with appropriate nutrition and lifestyle measures.
May enhance energy utilization
Through glucagon receptor activity, retatrutide may increase energy expenditure and promote the body’s use of stored fat, supporting improvements in body composition.
Supports metabolic health
Clinical studies suggest retatrutide may contribute to improvements in blood glucose regulation, insulin sensitivity, and cardiometabolic health markers.
Promotes long-term weight management
Regular treatment may help individuals maintain reduced calorie intake more comfortably, supporting long-term weight management and overall metabolic wellness.
What is Retatrutide
Retatrutide is an investigational peptide developed to support weight management and metabolic health. It is a triple-receptor agonist that targets GLP-1, GIP, and glucagon receptors, helping regulate appetite, energy balance, and glucose metabolism. Unlike traditional weight-loss approaches that rely solely on calorie restriction, retatrutide works through multiple biological pathways involved in body weight regulation.
How Retatrutide Works
Retatrutide acts by activating receptors involved in hunger control, satiety, and energy expenditure. This may help reduce food intake, increase feelings of fullness, and enhance the body’s ability to utilize stored energy. Its unique triple-agonist mechanism is designed to address several factors contributing to excess body weight and metabolic dysfunction.
Main Benefits of Retatrutide
Clinical research suggests retatrutide may support substantial weight reduction, improved appetite control, and better metabolic health markers. Potential benefits may include reductions in body fat, improvements in blood glucose regulation, enhanced insulin sensitivity, and support for long-term weight management.
Who Can Benefit from Retatrutide
Retatrutide is being studied for adults with overweight or obesity, particularly those seeking medical support for weight management and metabolic health. It may also be relevant for individuals with obesity-related health concerns, although further research and regulatory approvals are ongoing.
Usage and Precautions
Retatrutide is typically administered as a subcutaneous injection according to study protocols or healthcare provider guidance where applicable. Individual responses may vary based on factors such as body weight, diet, physical activity, and overall health status. Potential side effects may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, or reduced appetite. Medical supervision is recommended.
Disclaimer
Retatrutide is an investigational compound and may not be approved for general medical use in all countries. This product is intended for research purposes only where applicable. It is not intended to diagnose, treat, cure, or prevent any disease unless specifically approved by regulatory authorities. Always consult a qualified healthcare professional before use.
Related products
Reviews
There are no reviews yet.